CTRI/2024/02/062419招募中4 期
A, Single centric , assessor blind , open label randomized study to compare theefficacy and safety of the Tofacitinib versus methylprednisolone oral minipulsetherapy in vitiligo patients. - NI
Dr Imran Majid0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with a confirmed diagnosis of vitiligo, Washout period for Systemic medication for vitiligo for atleast 1 month before
- •enrolment, Written informed consent signed by the patient or legally acceptable
- •representative(s) in line with applicable regulation of country, Planned treatment in line with the Summary of Product Characteristics
排除标准
- •any contraindication to any of the oral medications, women of childbearing age, pregnancy, lactation, any family history of diabetes in parents/siblings, Confirmed case of Latent Tuberculosis on investigation, unwillingness to conform to study protocol
研究者
相似试验
已完成
3 期
A bridging clinical trial to evaluate the immunogenicity and safety of Three dose THRABIS vaccine in healthy childreCTRI/2023/03/050302Cadila Pharmaceutical Limited354
尚未招募
Unknown
Effect of the use of personal learning plans among trained first year medical students- a randomized trialCTRI/2023/08/056861Dr Rituparna Basu
尚未招募
4 期
Retrospective Clinical Investigation of Coronary StentsCTRI/2022/02/040336Multimedics LLP
招募中
Unknown
Clinical study of the test product in healthy human subjectsCTRI/2023/12/060417Dabur India Limited
进行中（未招募）
1 期
A study in male patients with newly diagnosed prostate cancer to assess the accuracy of an imaging tracer at diagnosing prostate cancer, in comparison to standard prostate biopsy. In addition, the study will collect additional data on the tracers safety, look at the possible ability in the tracer detecting cancer spread to nearby bone and look at the tumour uptake of the tracer.Prostate cancer (PCA) with high risk of metastasis.MedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-001815-19-DEDeutsches Krebsforschungszentrum (DKFZ), Stiftung des öffentlichen Rechts173